Announcements Trials

Browse Landscape

Phase

Status

Completed 19 Unknown 3 Withdrawn 1 Terminated 1 Recruiting 1

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 83 Carcinoma, Non-Small-Cell Lung 79 Breast Neoplasms 71 Leukemia, Myeloid, Acute 39 Recurrence 36 Colorectal Neoplasms 36 Prostatic Neoplasms 34 Neoplasm Metastasis 30 Multiple Myeloma 27 Pancreatic Neoplasms 25 Melanoma 25 Lymphoma 25 Lymphoma, Non-Hodgkin 24 Lung Neoplasms 23 Leukemia, Lymphocytic, Chronic, B-Cell 23 Ovarian Neoplasms 22 Lymphoma, Follicular 22 Carcinoma, Hepatocellular 22 Carcinoma, Renal Cell 21 Stomach Neoplasms 19 Squamous Cell Carcinoma of Head and Neck 19 Lymphoma, Large B-Cell, Diffuse 19 Precursor Cell Lymphoblastic Leukemia-Lymphoma 18 Myelodysplastic Syndromes 18 Urinary Bladder Neoplasms 17 Leukemia 17 Head and Neck Neoplasms 17 Hematologic Neoplasms 14 Carcinoma 13 Uterine Cervical Neoplasms 12

Interventions

Polyethylene Glycols 1 Colonoscopy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × INDUSTRY × Polyps × Clear all

NCT02893748 2019-09-23

HyGIeaCare Prep vs Split-dose PEG Prep Prior to Colonoscopy

HyGIeaCare, Inc.

Phase NA Withdrawn

Neoplasms, Polyps

Data powered by HemOnc (CC BY 4.0) Colophon ⚡